Abstract
The RADICALS-RT study (NEJM JW Oncol Hematol Nov 2020 and Lancet 2020 Sep 28; [e-pub]) showed that prostate-specific antigen (PSA) progression–free
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
